Table: Mochida Pharm -2020/21 group results

Mochida Pharmaceutical

14/05/2021 06:00

May 14 (Reuters)- 
          Mochida Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          103.00          101.80         101.50                 
               (+1.2 pct)      (-7.2 pct)     (-1.5 pct)               
  Operating       12.00            8.81           8.00                 
               (+36.3 pct)     (-16.8 pct)    (-33.4 pct)              
  Recurring       12.26            9.15           8.30                 
               (+33.9 pct)     (-16.2 pct)    (-32.3 pct)              
  Net
  Net              8.59            4.60           6.00                 
               (+86.8 pct)     (-45.5 pct)    (-30.1 pct)              
  EPS          222.29 yen      117.56 yen     156.78 yen               
  Ann Div       90.00 yen       80.00 yen      80.00 yen               
  -Q2 Div       40.00 yen       40.00 yen      40.00 yen               
  -Q4 Div       50.00 yen       40.00 yen      40.00 yen               
  
  NOTE - Mochida Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T